Sean Bohen, Olema CEO (AstraZeneca via YouTube)

Af­ter re­cruit­ing an As­traZeneca vet as CEO to head a new team and rais­ing $139M cash, lit­tle Ole­ma ap­pears to be ready to launch … some­thing

Sean Bo­hen is man­ag­ing his re-en­try in­to the R&D world in style. And he’s swerv­ing straight in­to the fast lane.

A cou­ple of weeks af­ter we chat­ted about the end of his sab­bat­i­cal fol­low­ing his de­par­ture from As­traZeneca as CMO and his new job as CEO of Ole­ma On­col­o­gy, Bo­hen took the wraps off of an $85 mil­lion in­vest­ment round that puts him in league with some of the high­est pro­file in­vestors in the field.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.